Skip to content

FENC

Fennec Pharmaceuticals Inc.

NASDAQ · USHealthcareBiotechnology
$10.30-1.90%

Price as of Jul 20, 2026

FENC ownership

Fennec Pharmaceuticals Inc. ownership & insider activity

Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
4
Net (3m)
-$322.2K
Insider trades by month Buys Sells
Jan
Feb
Apr
May
Jun
Jul
Context3-month price +53.8%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jul 2, 2026Raykov Rostyother: Former DirectorOption15,597$2.45
Jul 2, 2026Raykov Rostyother: Former DirectorGrant2,778
Jul 2, 2026Raykov Rostyother: Former DirectorSell9,599$10.41
Jul 1, 2026Evans Terry Lofficer: Chief Commercial OfficerGrant168
Jul 1, 2026Andrade Robertofficer: CHIEF FINANCIAL OFFICERGrant1,703
Jul 1, 2026Hackman Jeffrey S.director, officer: Chief Executive OfficerGrant1,159
Jul 1, 2026Sayad Pierre Sargisofficer: Chief Medical OfficerGrant168
Jul 1, 2026Cioffi Christiana Marieofficer: Chief Strategy OfficerGrant156
Jun 10, 2026Cook Jodi AdirectorGrant20,000$8.70
Jun 10, 2026RALLIS CHRIS AdirectorGrant20,000$8.70
Jun 10, 2026Islam KhaliddirectorGrant25,000$8.70
Jun 10, 2026Brughera Marco MariadirectorGrant20,000$8.70
Jun 2, 2026Raykov RostydirectorSell9,747$9.62
Jun 2, 2026Raykov RostydirectorGrant2,778
Jun 2, 2026Raykov RostydirectorOption15,597$2.45
Jun 1, 2026Cioffi Christiana Marieofficer: Chief Strategy OfficerGrant156
Jun 1, 2026Andrade Robertofficer: CHIEF FINANCIAL OFFICERGrant1,703
Jun 1, 2026Sayad Pierre Sargisofficer: Chief Medical OfficerGrant168
Jun 1, 2026Hackman Jeffrey S.director, officer: Chief Executive OfficerGrant1,159
Jun 1, 2026Evans Terry Lofficer: Chief Commercial OfficerGrant168
May 12, 2026RALLIS CHRIS AdirectorSell8,346$7.04
May 12, 2026RALLIS CHRIS AdirectorOption14,344$2.44
May 1, 2026Hackman Jeffrey S.director, officer: Chief Executive OfficerOption1,159
May 1, 2026Andrade Robertofficer: CHIEF FINANCIAL OFFICEROption1,703
May 1, 2026Sayad Pierre Sargisofficer: Chief Medical OfficerOption168
May 1, 2026Raykov RostydirectorOption2,778
May 1, 2026Evans Terry Lofficer: Chief Commercial OfficerOption168
May 1, 2026Cioffi Christiana Marieofficer: Chief Strategy OfficerOption155
May 1, 2026Raykov RostydirectorOption15,598$2.45
May 1, 2026Raykov RostydirectorSell10,781$6.47

Source: FENC SEC Form 4 filings, latest Jul 2, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their FENC positions over the last 6 months (SEC Form 13F).

Increased
65
New positions
35
Reduced
44
Sold out
30
Largest moves
InstitutionActionSharesFiled
ROSALIND ADVISORS, INC.Increased2.9MMay 14, 2026
SOUTHPOINT CAPITAL ADVISORS LPUnchanged2.7MMay 15, 2026
SOUTHPOINT CAPITAL ADVISORS LPReduced2.7MFeb 17, 2026
ROSALIND ADVISORS, INC.Increased2.6MFeb 12, 2026
SOLAS CAPITAL MANAGEMENT, LLCIncreased2.6MFeb 17, 2026
SOLAS CAPITAL MANAGEMENT, LLCReduced2.5MMay 15, 2026
AIGH CAPITAL MANAGEMENT LLCIncreased2.0MApr 30, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1.8MMay 15, 2026
AIGH CAPITAL MANAGEMENT LLCIncreased1.6MFeb 2, 2026
BLACKROCK, INC.Increased1.4MMay 13, 2026
BLACKROCK, INC.Increased1.2MFeb 12, 2026
VANGUARD GROUP INCIncreased1.1MJan 29, 2026
AWM INVESTMENT COMPANY, INC.Increased720KMay 15, 2026
AWM INVESTMENT COMPANY, INC.New Position712KFeb 13, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased372KMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.